Dawn Parsell
2020
In 2020, Dawn Parsell earned a total compensation of $3.8M as Executive Vice President, Clinical Development at Tricida, a 30% increase compared to previous year.
Compensation breakdown
| Bonus | $16,316 |
|---|---|
| Non-Equity Incentive Plan | $54,600 |
| Option Awards | $3,280,636 |
| Salary | $434,000 |
| Stock Awards | $46,840 |
| Total | $3,832,392 |
Parsell received $3.3M in option awards, accounting for 86% of the total pay in 2020.
Parsell also received $16.3K in bonus, $54.6K in non-equity incentive plan, $434K in salary and $46.8K in stock awards.
Rankings
In 2020, Dawn Parsell's compensation ranked 2,988th out of 13,090 executives tracked by ExecPay. In other words, Parsell earned more than 77.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,988 out of 13,090 | 77th |
Division Manufacturing | 1,162 out of 5,624 | 79th |
Major group Chemicals And Allied Products | 438 out of 2,257 | 81st |
Industry group Drugs | 380 out of 1,957 | 81st |
Industry Pharmaceutical Preparations | 281 out of 1,462 | 81st |
Source: SEC filing on April 23, 2021.
Parsell's colleagues
We found five more compensation records of executives who worked with Dawn Parsell at Tricida in 2020.
News
Tricida CEO Gerrit Klaerner's 2021 pay falls 47% to $4.7M
April 25, 2022
Tricida CEO Gerrit Klaerner's 2020 pay slips 13% to $8.9M
April 23, 2021
Tricida CEO Gerrit Klaerner's 2019 pay jumps 579% to $10M
April 29, 2020
Tricida Senior Vice President of Clinical Development Dawn Parsell receives $3.7M in 2018
April 18, 2019